MM-141: Clinical Trials

1 trial of MM-141, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow MM-141: new trials by email Literature Review of MM-141 trials Research Report on MM-141

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer
MM-141, Placebo, Gemcitabine - Pancreatic Cancer
Phase 2CompletedMerrimack Pharmaceuticals882015-05-012018-09-18

Conditions studied

Fibromatosis, Gingival, 2 (1)  ·  Pancreatic Neoplasms (1)

Sponsors

Merrimack Pharmaceuticals (1)

Countries

Canada (1)  ·  Germany (1)  ·  Poland (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

Results publications

PMID 31912800